Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study

Table 3

Descriptive statistics of the 10 enrolled patients.

Age (years)	75,2±5,94
Sex
Male	3 (30%)
Female	7 (70%)
Smokers	2 (20%)
Cancer
Multiple Myeloma	4 (40%)
Breast cancer	3 (30%)
Prostate cancer	3 (30%)
Comorbidities
Diabetes	2 (20%)
Hypertensions	6 (60%)
Corticosteroids	2 (20%)
Osteoporosis	5 (50%)
Chemotherapy	5 (50%)
Rheumatoid arthritis	1 (10%)
Involved bone
Maxilla	1 (10%)
Mandible	9 (90%)
BRONJ stage
I A	0
I B	6 (60%)
II A	2 (20%)
II B	2 (20%)
Bone exposure
Yes	8 (80%)
No	2 (20%)
Intravenous Bisphosphonates treatment time (mo)	31,8±25,76

BRONJ stage according to SICMF-SIPMO clinical and radiological staging system.